Paxman AB (publ) Stock Nasdaq Stockholm
Equities
SE0009806284
Medical Equipment, Supplies & Distribution
Sales 2024 * | 292M 27.77M 38.06M | Sales 2025 * | 401M 38.13M 52.27M | Capitalization | 856M 81.36M 112M |
---|---|---|---|---|---|
Net income 2024 * | 34M 3.23M 4.43M | Net income 2025 * | 84M 7.99M 10.95M | EV / Sales 2024 * | 2.79 x |
Net cash position 2024 * | 42M 3.99M 5.47M | Net cash position 2025 * | 97M 9.22M 12.64M | EV / Sales 2025 * | 1.89 x |
P/E ratio 2024 * |
25
x | P/E ratio 2025 * |
10.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 35.76% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Paxman
CEO | Chief Executive Officer | 41 | 16-12-19 |
Director of Finance/CFO | 44 | 20-02-29 | |
Emma Thornhill
DFI | Director of Finance/CFO | 39 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Björn Littorin
BRD | Director/Board Member | 77 | 16-11-30 |
Chairman | 70 | 16-11-30 | |
Maria Bech
BRD | Director/Board Member | 56 | 16-12-19 |
1st Jan change | Capi. | |
---|---|---|
-4.20% | 185B | |
-1.51% | 105B | |
-2.27% | 68.9B | |
+15.85% | 46.41B | |
-6.56% | 46.16B | |
+5.36% | 40.75B | |
+20.49% | 31.11B | |
+11.60% | 24.26B | |
-6.51% | 23.94B |